Wikipedia
Sovaprevir
Sovaprevir (ACH-1625) is an experimental drug designed to treat the hepatitis C virus. It is under development by Achillion Pharmaceuticals.
Sovaprevir received Fast Track status from the U.S. Food and Drug Administration (FDA) in 2012.